Pirfenidone Inhibits Dimethylnitrosamine‐Induced Hepatic Fibrosis In Rats
- 21 July 2001
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 28 (7) , 522-527
- https://doi.org/10.1046/j.1440-1681.2001.03481.x
Abstract
1. In the present study, we investigated the preventive effects of pirfenidone (PFD), an antifibrotic agent, on experimental hepatic fibrosis induced by dimethylnitrosamine (DMN) in rats. 2. Treatment with DMN caused a significant decrease in bodyweight and liver weight. Oral PFD (500 mg/kg daily for 4 weeks) essentially prevented this DMN‐induced loss in bodyweight and tended to suppress the loss in liver weight. There were no significant differences in liver weight and serum L‐alanine aminotransferase levels between PFD‐treated and ‐untreated groups. Pirfenidone has no major side effects in vivo. 3. Pirfenidone suppressed the induction of hepatic fibrosis determined by histological evaluation and reduced hepatic hydroxyproline levels. Expression of mRNA for type I collagen and transforming growth facter‐β in the liver was also suppressed by PFD treatment. 4. Because hepatic stellate cells (HSC) are the major cellular source of extracellular matrix in hepatic fibrosis, we examined the effects of PFD on type I collagen production in vitro using rat primary HSC cultures. Pirfenidone inhibited collagen production in HSC culture in a dose‐dependent manner. 5. These results demonstrate that the inhibitory effects of PFD against hepatic fibrosis may be due, at least in part, to blockade of collagen production by HSC and suggest that PFD may be potentially useful in the prevention of the development of hepatic fibrosis.Keywords
This publication has 28 references indexed in Scilit:
- Cytokine Regulation of Hepatic Stellate Cells in Liver FibrosisAlcohol, Clinical and Experimental Research, 1999
- Expression of Collagen α1(I) mRNA Variants during Tooth and Bone Formation in the RatJournal of Dental Research, 1999
- Stimulation of collagen α1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: A link to tissue fibrosis?,Hepatology, 1994
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesNew England Journal of Medicine, 1993
- Hepatic Fibrosis — New Therapeutic ApproachesNew England Journal of Medicine, 1991
- Cellular Sources of Collagen and Regulation of Collagen Production in LiverSeminars in Liver Disease, 1990
- Cellular Sources of Noncollagenous Matrix Proteins: Role of Fat-Storing Cells in FibrogenesisSeminars in Liver Disease, 1990
- Dimethylnitrosamine-induced cirrhosisJournal of Hepatology, 1989
- A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the ratJournal of Hepatology, 1987
- Cell Types Involved in Collagen and Fibronectin Production in Normal and Fibrotic Human LiverHepatology, 1986